Chemical Structure (Zarontin 01)
Zarontin Solution
Product Images NDC 0071-2418
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Zarontin (NDC 0071-2418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Parke-davis Div Of Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Company Logo (Zarontin 02)
Sefizer is a product that is distributed by Parke-Davis, which is a division of Pfizer Inc. The company is located in New York, NY 10017.*
Logo (Zarontin 02a)
Sefizer is a product or brand name that is distributed by Parke-Davis, which is a division of Pfizer Inc. located in New York, NY 10017.*
Principal Display Panel (474 mL Bottle Label)
This is a medication guide for Zarontin® oral solution, containing 250mg per 5 liters of Ethosuximide in a raspberry flavored base. It is recommended to always dispense medication with the accompanying medication guide. The solution should be stored at 20°-25°C (66°-77°F) in tight containers and protected from freezing and light. The dispensing container must be child-resistant and light-resistant as defined in the USP. For dosage and use, please refer to the accompanying prescribing information. This medication is distributed by Parke-Davis Division of Pize Inc, NY, NY 10017. No other details are available from the given text.*
Principal Display Panel (474 mL Bottle Carton)
This is a description of a medication called Zarontin® which is distributed by Parke-Davies. It contains the active ingredient Ethosuximide and is available in oral solution form. Each 5 mL of oral solution contains 250 mg of Ethosuximide. The medication is dispensed in a tight and resistant container and has a rispberry flavor. There are contact details for Parke-Davies included, and the medication is available in divisons of 1 Pint (474 L).*
Principal Display Panel (474 mL Bottle Label)
Zarontin is an oral solution medication containing Ethosuximide. Each 5mL of this raspberry-flavored base medication contains 250mg of ethosuximide. The medication guide should always be dispensed with this medication. The medication should be stored at a temperature ranging from 20°C-25°C (68°F-77°F), in tightly sealed, light-resistant and child-resistant containers. The medication should be protected from freezing and light. Please see the accompanying prescribing information for the dosage and usage directions. This medication is distributed by Parke-Davis, a division of Pfizer Inc in NY, NY.*
Principal Display Panel (474 mL Bottle Carton)
This is a description for a medication called Zarontin® (Ethosuximide) in the form of an oral solution, distributed by Parke-Davis Division of Pfizer Inc in New York. The solution comes in raspberry flavor and each 5 mL of oral solution contains 250 mg ethosuximide. The prescription information should be consulted for dosage and use instructions. The medication should be dispensed and stored in tight and light-resistant child-resistant containers.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
